Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The current study will recruit lung cancer patients to measure tissue protein synthesis rates of non-small cell lung carcinomas and healthy lung tissue. The protein synthesis rates of healthy lung tissue will be compared to lung tumor tissue to establish the remodeling characteristics of healthy versus cancerous lung tissues. We will also examine whether tissue protein synthesis rates of non-small cell lung carcinomas are associated with various tumor- (i.e., size, subclassification) and patient-derived (i.e., inflammation, lung function, smoking status, and smoking history) parameters.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Lung cancer patient | Lung cancer patients diagnosed a non-small cell lung carcinoma requiring resection surgery. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| There are no interventions in the present study | Other | There are no interventions in the present study |
|
| Measure | Description | Time Frame |
|---|---|---|
| Lung tumor fractional synthetic rate | units: % per day | 5 days prior to surgery |
| Lung tissue fractional synthetic rate | units: % per day | 5 days prior to surgery |
| Muscle tissue fractional synthetic rate | units: % per day | 5 days prior to surgery |
| Measure | Description | Time Frame |
|---|---|---|
| Plasma glucose concentrations | units: mmol/L | Baseline |
| Plasma insulin concentrations | units: pmol/L | Baseline |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
In total, we will recruit 30 lung cancer patients (diagnosed with a NSCLC) scheduled to undergo surgery. The nature and the risks of the experimental procedures will be explained to all subjects before their informed consent will be obtained. All subjects will be recruited through contact with their Surgeon at the Department of surgery at Zuyderland Medical Centre, Heerlen.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Andrew Holwerda, PhD | Contact | +31433881381 | andy.holwerda@maastrichtuniversity.nl |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Zuyderland Medical Center | Recruiting | Heerlen | Limburg | 6419 PC | Netherlands |
There is currently no plan to share data with other researchers.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D008175 | Lung Neoplasms |
| ID | Term |
|---|---|
| D012142 | Respiratory Tract Neoplasms |
| D013899 | Thoracic Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
| Plasma GH concentrations | units: mU/L | Baseline |
| Plasma IGF-1 concentrations | units: nmol/L | Baseline |
| Plasma IGFBP-1 concentrations | units: ug/L | Baseline |
| Plasma IGFBP-3 concentrations | units: ug/L | Baseline |
| Plasma CRP concentrations | units: mg/L | Baseline |
| Plasma IL-1 concentrations | units: ng/L | Baseline |
| Plasma IL-6 concentrations | units: ng/L | Baseline |
| Plasma IL-10 concentrations | units: ng/L | Baseline |
| Plasma TNF-alpha concentrations | units: ng/L | Baseline |
| D008171 |
| Lung Diseases |
| D012140 | Respiratory Tract Diseases |